6 Votes
Arthritis patients taking newer treatments do not have an overall increased cancer risk, research finds
http://feeds.sciencedaily.com —
Newer biologic treatments, including infliximab (Remicade), adalimumab (Humira), certolizumab pegol (Cimzia), golimumab (Simponi) and etanercept (Enbrel), used in patients with arthritis do not increase the risk of cancer, according to data from over 13,000 patients.
Comments